Rosália Morais Torres
Universidade Federal de Minas Gerais
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rosália Morais Torres.
Epidemiologia e Serviços de Saúde | 2016
João Carlos Pinto Dias; Alberto Novaes Ramos; Eliane Dias Gontijo; Alejandro O. Luquetti; Maria Aparecida Shikanai-Yasuda; José Rodrigues Coura; Rosália Morais Torres; José Renan da Cunha Melo; Eros Antonio de Almeida; Wilson de Oliveira; Antônio Carlos Silveira; Joffre Marcondes de Rezende; Fabiane Scalabrini Pinto; Antonio Walter Ferreira; Anis Rassi; Abilio Augusto Fragata Filho; Andréa Silvestre de Sousa; Dalmo Correia Filho; Ana Maria Jansen; Gláucia Manzan Queiroz de Andrade; Constança Britto; Ana Yecê das Neves Pinto; Dayse Elisabeth Campos; Fernando Abad-Franch; Silvana Maria Elói Santos; Egler Chiari; Alejandro Marcel Hasslocher-Moreno; Eliane Furtado Moreira; Divina Seila de Oliveira Marques; Eliane Lages Silva
Chagas disease is a neglected chronic condition that presents high morbidity and mortality burden, with considerable psychological, social, and economic impact. The disease represents a significant public health issue in Brazil, with different regional patterns. This document presents the evidence that resulted in the Brazilian Consensus on Chagas Disease. The objective was to review and standardize strategies for diagnosis, treatment, prevention, and control of Chagas disease in the country, based on the available scientific evidence. The consensus is based on collaboration and contribution of renowned Brazilian experts with vast knowledge and experience on various aspects of the disease. It is the result of close collaboration between the Brazilian Society of Tropical Medicine and the Ministry of Health. This document shall strengthen the development of integrated control measures against Chagas disease in the country, focusing on epidemiology, management, comprehensive care (including families and communities), communication, information, education, and research.
Revista Da Sociedade Brasileira De Medicina Tropical | 2016
João Carlos Pinto Dias; Alberto Novaes Ramos; Eliane Dias Gontijo; Alejandro O. Luquetti; Maria Aparecida Shikanai-Yasuda; José Rodrigues Coura; Rosália Morais Torres; José Renan da Cunha Melo; Eros Antonio de Almeida; Wilson de Oliveira; Antônio Carlos Silveira; Joffre Marcondes de Rezende; Fabiane Scalabrini Pinto; Antonio Walter Ferreira; Anis Rassi; Abilio Augusto Fragata Filho; Andréa Silvestre de Sousa; Dalmo Correia; Ana Maria Jansen; Gláucia Manzan Queiroz de Andrade; Constança Britto; Ana Yecê das Neves Pinto; Dayse Elisabeth Campos; Fernando Abad-Franch; Silvana Maria Elói Santos; Egler Chiari; Alejandro Marcel Hasslocher-Moreno; Eliane Furtado Moreira; Divina Seila de Oliveira Marques; Eliane Lages Silva
Chagas disease is a neglected chronic condition with a high burden of morbidity and mortality. It has considerable psychological, social, and economic impacts. The disease represents a significant public health issue in Brazil, with different regional patterns. This document presents the evidence that resulted in the Brazilian Consensus on Chagas Disease. The objective was to review and standardize strategies for diagnosis, treatment, prevention, and control of Chagas disease in the country, based on the available scientific evidence. The consensus is based on the articulation and strategic contribution of renowned Brazilian experts with knowledge and experience on various aspects of the disease. It is the result of a close collaboration between the Brazilian Society of Tropical Medicine and the Ministry of Health. It is hoped that this document will strengthen the development of integrated actions against Chagas disease in the country, focusing on epidemiology, management, comprehensive care (including families and communities), communication, information, education, and research .
Revista Do Instituto De Medicina Tropical De Sao Paulo | 2006
Jaila Dias Borges; Girley Francisco Machado de Assis; Lizziani Vasconcelos Gomes; João Carlos Pinto Dias; Ildikô Delkim Miranda Pinto; Olindo Assis Martins-Filho; Rosália Morais Torres; Pedro Albajar Viñas; Maria Terezinha Bahia; George Luiz Lins Machado-Coelho; Marta de Lana
Six years after the beginning of the epidemiological surveillance of Chagas disease in Berilo and José Gonçalves de Minas, Jequitinhonha Valley, MG, Brazil, a serological inquiry was performed to observe whether the transmission of this endemy was occurring in this area. A randomized sample of 1,412 children seven to 14 years old, was screened. Six asymptomatic children were found to be positive, leading to 0.4% of prevalence. Hemoculture confirmed infection in five out of the six positive cases. Additional epidemiological investigation revealed important antecedents, such as disease reports in relatives and predisposing ecological and housing conditions. Our results demonstrated similar seroprevalence (0.4%) in schoolchildren, ranging from seven to 14 years old, and that were observed six years ago (0.2%) for children 0-9 year-old. Thus, considering the constant presence of Panstrogylus megistus in the peridomicile these findings emphasize the need of continuous improved epidemiological surveillance of Chagas disease in this region.
Memorias Do Instituto Oswaldo Cruz | 2013
Girley Francisco Machado-de-Assis; Glaucia Alessio Diniz; Roberto Montoya; João Carlos Pinto Dias; José Rodrigues Coura; George Luiz Lins Machado-Coelho; Pedro Albajar-Viñas; Rosália Morais Torres; Marta de Lana
The etiological treatment of Chagas disease is recommended for all patients with acute or recent chronic infection, but controversies remain regarding the benefit of chemotherapy and interpretations of the parasitological cure after etiological treatment. This study compares the laboratory and clinical evaluations of Chagas disease patients who were diagnosed 13 years earlier. Fifty-eight Chagas disease patients (29 treated with benznidazole and 29 untreated) were matched at the time of treatment based on several variables. Conventional serology revealed the absence of seroconversion in all patients. However, lower serological titres were verified in the treated group, primarily among patients who had the indeterminate form of the disease. Haemoculture performed 13 years after the intervention was positive for 6.9% and 27.6% of the treated and untreated patients, respectively. Polymerase chain reaction tests were positive for 44.8% and 13.8% of the treated and untreated patients, respectively. Patients who presented with the indeterminate form of the disease at the beginning of the study exhibited less clinical progression (17.4%) compared with the untreated group (56.5%). Therefore, this global analysis revealed that etiological treatment with benznidazole may benefit patients with respect to the clinical progression of Chagas disease and the prognosis, particularly when administered to patients with the indeterminate form of the disease.
Revista Da Sociedade Brasileira De Medicina Tropical | 2012
Lilian da Silva Santos; Rosália Morais Torres; Girley Francisco Machado-de-Assis; Maria Terezinha Bahia; Helen Rodrigues Martins; Andréa Teixeira-Carvalho; Jordana Grazziela Coelho-dos-Reis; Pedro Albajar-Viñas; Olindo Assis Martins-Filho; Marta de Lana
INTRODUCTION The goal was to develop an in-house serological method with high specificity and sensitivity for diagnosis and monitoring of Chagas disease morbidity. METHODS With this purpose, the reactivities of anti-T. cruzi IgG and subclasses were tested in successive serum dilutions of patients from Berilo municipality, Jequitinhonha Valley, Minas Gerais, Brazil. The performance of the in-house ELISA was also evaluated in samples from other relevant infectious diseases, including HIV, hepatitis C (HCV), syphilis (SYP), visceral leishmaniasis (VL), and American tegumentary leishmaniasis (ATL), and noninfected controls (NI). Further analysis was performed to evaluate the applicability of this in-house methodology for monitoring Chagas disease morbidity into three groups of patients: indeterminate (IND), cardiac (CARD), and digestive/mixed (DIG/Mix), based on their clinical status. RESULTS The analysis of total IgG reactivity at serum dilution 1:40 was an excellent approach to Chagas disease diagnosis (100% sensitivity and specificity). The analysis of IgG subclasses showed cross-reactivity, mainly with NI, VL, and ATL, at all selected serum dilutions. Based on the data analysis, the IND group displayed higher IgG3 levels and the DIG/Mix group presented higher levels of total IgG as compared with the IND and CARD groups. CONCLUSIONS These findings demonstrated that methodology presents promising applicability in the analysis of anti-T. cruzi IgG reactivity for the differential diagnosis and evaluation of Chagas disease morbidity.
Arquivos Brasileiros De Cardiologia | 2014
Lavinia Pimentel Miranda; Paulo Augusto Moreira Camargos; Rosália Morais Torres; Zilda Maria Alves Meira
Background Previous studies indicate that compared with physical examination, Doppler echocardiography identifies a larger number of cases of rheumatic heart disease in apparently healthy individuals. Objectives To determine the prevalence of rheumatic heart disease among students in a public school of Belo Horizonte by clinical evaluation and Doppler echocardiography. Methods This was a cross-sectional study conducted with 267 randomly selected school students aged between 6 and 16 years. students underwent anamnesis and physical examination with the purpose of establishing criteria for the diagnosis of rheumatic fever. They were all subjected to Doppler echocardiography using a portable machine. Those who exhibited nonphysiological mitral regurgitation (MR) and/or aortic regurgitation (AR) were referred to the Doppler echocardiography laboratory of the Hospital das Clínicas of the Universidade Federal of Minas Gerais (HC-UFMG) to undergo a second Doppler echocardiography examination. According to the findings, the cases of rheumatic heart disease were classified as definitive, probable, or possible. Results Of the 267 students, 1 (0.37%) had a clinical history compatible with the diagnosis of acute rheumatic fever (ARF) and portable Doppler echocardiography indicated nonphysiological MR and/or AR in 25 (9.4%). Of these, 16 (6%) underwent Doppler echocardiography at HC-UFMG. The results showed definitive rheumatic heart disease in 1 student, probable rheumatic heart disease in 3 students, and possible rheumatic heart disease in 1 student. Conclusion In the population under study, the prevalence of cases compatible with rheumatic involvement was 5 times higher on Doppler echocardiography (18.7/1000; 95% CI 6.9/1000-41.0/1000) than on clinical evaluation (3.7/1000-95% CI).
Arquivos Brasileiros De Cardiologia | 2013
Rose Mary Ferreira Lisboa da Silva; Nadya Mendes Kazzaz; Rosália Morais Torres; Maria da Consolação Vieira Moreira
BACKGROUND Studies have shown that P-wave dispersion (PWD) and left atrial volume index (LAVi) are predictors of cardiovascular events (CE). OBJECTIVE To verify the prognostic value of PWD and LAVi for the occurrence of CE in patients with heart failure (HF). METHODS This was a longitudinal prospective study of 78 consecutive patients with a mean age of 47.2 years, of which 52 were males. Patients had stable HF and underwent clinical evaluation, electrocardiogram and echocardiogram assessments, with a follow-up of 26.5 months. RESULTS The means of the variables were: 50 ms for PWD and 35.5 mL/m² for LAVi. Considering PWD > 40 ms and, as reference, LAVi > 28 mL/m², the positive predictive value of PWD was 87.5% and the negative predictive value was 76.9%. During follow-up, 21 patients had CE. There was an association between left atrial measurements, left ventricular volumes, ejection fraction and CE. There was no association between PWD and CE. At the multivariate analysis, the left atrium and LAVi were predictors of events (p = 0.00 and 0.02). Through the operating characteristic curve for the variable stable CE, areas of 0.80 and 0.69 were obtained for LAVi (p = 0.00) and LAVi > 28 mL/m² (p = 0.01). Survival curves (Kaplan-Meier) free of those events for LAVi > 28 mL/m² and for Chagas disease etiology showed an odds ratio of 14.4 (p = 0.00) and 3.2 (p = 0.03). There was no difference in outcome between patients with ischemic and nonischemic heart failure. CONCLUSION PWD was not correlated to CE. LAVi was an independent predictor of CE, and chagasic patients showed worse outcomes.
Revista Brasileira De Cirurgia Cardiovascular | 2005
Cláudio Léo Gelape; Marcelo Dias Sanches; Rosália Morais Torres; Cláudia Alves Couto; Pedro Corrêa Paixão; Klaus Morales; José Renan da Cunha Melo
OBJECTIVE: To evaluate the diastolic left ventricular function by echocardiography one and three weeks after acute myocardial infarction (AMI). METHOD: Nineteen Wistar rats (mean 209 g) were utilized. After anesthesia with ketamine (50mg/kg) and xylazine (10mg/kg), the left coronary artery was ligated after left thoracotomy to cause myocardial infarction. The animals were divided in two groups: group A (control, n=7) and group B (n=9). Echocardiographic evaluation was undertaken in the control group and one week (B1, n=9) and three weeks (B3, n=8) post-AMI in group B animals. The cardiac function was evaluated using a 21275 A HP Sonos 1500 Echocardiography equipped with 7.5/5.5 MHz transducer. Diastolic function was evaluated by transmitral flow, by analysis of the A wave, E wave and atrial left volume (LAV). Histological specimens were evaluated on third week. RESULTS: There were no differences on E wave analyses (A=62cm/s, B1=65cm/s, B3=69cm/s) or A wave analyses (A=43cm/s, B1=40cm/s, B3=41cm/s) between the groups. There was an increase in LAV; A vs B1 and A vs B3 (A=0.05mL vs B1=0.15mL, p=0.04 e A vs B3=0.14mL, p=0.01). Histological examination confirmed AMI in all animals. CONCLUSIONS: The LAV may be useful to assess the diastolic function in rats with AMI. LAV could reflect increases in left ventricular end-diastolic pressure secondary to systolic or diastolic dysfunction.
Parasitology Research | 2018
Ana Paula Braga Lima; Maykon Tavares de Oliveira; Rafael Rodrigues Silva; Rosália Morais Torres; Vanja Maria Veloso; Marta de Lana; Glenda Nicioli da Silva
Chagas disease, caused by the protozoan Trypanosoma cruzi, is considered to be a multifactorial disease associated with host and parasite genetics, which influence clinical aspects of the disease and other host conditions. In order to understand better the evolution of the disease, this study intended to evaluation of parasite and host genetics in two generations of a family with Chagas disease from the Alto Paranaiba region, Minas Gerais, Brazil, comprising a mother and her five daughters. Several features were evaluated, including the characterization of T. cruzi directly from the blood of patients, host polymorphisms of genes related to cardiomyopathy (TNF, WISP1, CCR5, and TGF-β1) and clinical aspects of the patients. To verify the intraspecific variability of the parasite, the characterization was done directly from human blood using the PCR-LSSP technique and analyzed based on Dice coefficient and unweighted pair group analysis (UPGMA). The host polymorphism was evaluated by PCR-RFLP. The global results showed low variability of the parasites characterized from blood of patients, through Shannon index (0.492) and mean heterozygosity value per locus (0.322). All six patients presented the same genetic polymorphism profile for TNF, WISP1, and TGF-β1, and only one patient was homozygous to CCR5, which suggests that there is no association between the clinical aspects of the patients and their genetic profiles. In conclusion, the findings confirm that the understanding of the clinical evolution of Chagas disease goes beyond the genetic aspects of the parasite and the host.
Archive | 2012
Alaneir de Fátima dos Santos; Humberto José Alves; Cláudio de Souza; Rosália Morais Torres; Maria do Carmo Barros de Melo
The World Health Organization (WHO, 2007) is confident that the major expectations regarding public health will be met in the 21st century as a result of improved access to resources – both qualitatively and quantitatively, which will then be available to most of the world population. Building on the assumption that the technological development has yielded significant contributions to the health field, particularly by facilitating knowledge sharing and promoting care education and training either in remote and isolated areas, WHO encourages its members to adopt telehealth as a politic and strategic tool to plan and implement health actions worldwide.